Deciphering therapeutic targets

BioTechniques

Volumn 30, Issue 5, 2001, Pages 1086-1090

  Sawyer, Tomi K ^a  

^a ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; HUMAN; SEQUENCE ANALYSIS; TECHNOLOGY;

EID: 0035024984     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/01305dd01     Document Type: Article

References (21)

1. Aebersold, R., and D.R. Goodlet. 2001. Mass spectrometry in proteomics. Chem. Rev. 101:269-295.
2. Birney, W., A. Bateman, M.E. Clamp, and T.J. Hubbard. 2001. Mining the draft human genome. Nature 409:827-828.
3. Caron, H., B. van Schaik, M van der Mee, F. Baas, G. Riggins, P. van Sluis, M.-C. Hermus et al. 2001. The human transcriptome map: clustering of highly expressed genes in chromasomal domains. Science 291:1289-1292.
4. Davies, P.A., M. Pistis, M.C. Hanna, J.A. Peters, J.J. Lambert, T.G. Hales, and E.F. Kirkness. 1999. The 5-HT3B subunit is a major determinant of seratonin-receptor function. Nature 397:359-363.
5. Drews, J. 2000. Drug discovery: a historical perspective. Science 287:1960-1964.
6. Fan, W., B.D. Bennett, S. Babu-Kahn, Y. Luo, J.-C. Louis, M. McCaleb, M. Citron, R. Vassar, and W.G. Richards. 1999. BACE maps to chromosome 11 and BACE homolog, BACE2, reside in the obligate Down Syndrome region of chromasome 21. Science 286:1255.
7. Futreal, P.A., A Kasprzyk, E. Birney, J.C. Mullikin, R. Wooster, and M.R. Stratton. 2001. Cancer and genomics. Nature 409:850-852.
8. Harris, S. and S.M. Foord. 2000. Transgenic gene knock-outs: functional genomics and therapeutic target selection. Pharmacogenomcs. 1:433-443.
9. Heise, C.E., B.F. O'Dowd, D.J. Figueros, N. Sawyer, T. Nguyen, D.S. Im, R. Stocco, J.N. Bellfeuille et al. 2000. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275:30531-30536.
10. International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
11. International Mouse Mutagenesis Consortium. 2001. Functional annotation of mouse genome sequences. Science 291:1251-1255.
12. International SNP Map Working Group. 2001. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-933.
13. Jimenez-Sanchez, G., B. Childs, B., and D. Valle. 2001. Human disease genes. Nature 409:853-855.
14. Legrain, P. and L. Selig. 2000. Genome-wide protein interaction maps using two-hybrid systems. FEBS Lett. 480:32-36.
15. Nolan, P.M. 2000. Generation of mouse mutants as a tool for functional genomics. Pharmacogenomics 1:243-255.
16. Roos, D.S. 2001. Bioinformatics - trying to swim in a sea of data. Science 291:1260-1261.
17. Rosamond, J. and A. Allsop. 2001. Harnessing the power of the genome in the search for new antibiotics. Science 287:1973-1976.
18. Sander, C. 2000. Genomic medicine and the future of health care. Science 287:1977-1978.
19. Shoemaker, D.D., E.E. Schadt, C.D. Armour, Y.D. He, P. Garrett-Engele, P.D. McDonaugh, P.M. Loerch et al. 2001. Experimental annotation of the human genome using microarray technology. Nature 409:922-927.
20. Venter, J.C., M.D. Adams, E.W. Myers, P.W. Li, R.J. Mural, G.G. Sutton, H.O. Smith et al. 2001. The sequence of the human genome. Science 291:1304-1351.
21. Yoshida, M., J.A. Loo, and R.A. Lepley, 2001. Proteomics as a tool in the pharmaceutical drug design process. Curr. Pharm. Des. 7:291-310.